A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2017-09-07
Summary
A Single-Dose Study to Evaluate the Effects of ABX-1431 on Gastric Accommodation and Nutrient Volume Tolerance in Patients with Functional Dyspepsia.
Conditions
- Dyspepsia
Interventions
- DRUG
-
ABX-1431
Single-dose ABX-1431
- DRUG
-
Single-dose matching placebo
Sponsors & Collaborators
-
Abide Therapeutics
lead INDUSTRY
Principal Investigators
-
Chan Beals, MD,PhD · Abide Therapeutics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-22
- Primary Completion
- 2017-08-07
- Completion
- 2017-08-07
Countries
- Belgium
Study Locations
More Related Trials
-
Confocal Laser Endomicroscopy Based Diet in Functional Dyspepsia
NCT05666154 ·Status: RECRUITING ·Phase: NA
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
NCT02151708 ·Status: UNKNOWN ·Phase: NA
-
Budesonide as a Treatment for Functional Dyspepsia
NCT06841406 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Motilitone to Treat Functional Dyspepsia
NCT02365701 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Secretin in Functional Dyspepsia and Healthy Subjects
NCT03617861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA
-
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
NCT00761358 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Of Itopride On Gastric Emptying And Accommodation In Patients With Functional Dyspepsia
NCT01226134 ·Status: UNKNOWN ·Phase: NA
-
Postprandial Distress Itopride Cohort Trial
NCT07165301 ·Status: NOT_YET_RECRUITING
-
Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis
NCT01519180 ·Status: COMPLETED
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia
NCT03856294 ·Status: COMPLETED ·Phase: PHASE2
-
Tradipitant for Functional Dyspepsia
NCT05653310 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
NCT05513040 ·Status: RECRUITING
-
Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia
NCT07196735 ·Status: RECRUITING
-
GI Tolerance and Acceptability of a New Thickener
NCT04104815 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Z-338 in Subjects With and Without Functional Dyspepsia
NCT00298194 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
NCT02567578 ·Status: TERMINATED ·Phase: PHASE2
-
Responses to a Comfort Meal in Functional Dyspepsia
NCT04722419 ·Status: COMPLETED ·Phase: NA
-
Mast Cells in Acid-induced Intestinal Permeability
NCT02664051 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method
NCT02091635 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction
NCT01410071 ·Status: TERMINATED
-
The Six Food Elimination in Postprandial Distress Syndrome
NCT05651386 ·Status: RECRUITING ·Phase: NA
-
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
NCT07324785 ·Status: RECRUITING